TALEN

TALEN1-mpl

ID
ZDB-TALEN-170804-1
Name
TALEN1-mpl
Previous Names
None
Target
Target Sequence 1
5' - AGAAGACTTCACTTGCT - 3'
Target Sequence 2
5' - CATAGGACTTTTCAAC - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
sm10 mpl
Expression
Gene expression in Wild Types + TALEN1-mpl
No data available
Phenotype
Phenotype resulting from TALEN1-mpl
No data available
Phenotype of all Fish created by or utilizing TALEN1-mpl
Phenotype Fish Conditions Figures
head kidney runx1 expression decreased amount, abnormal mplsm10/sm10 (AB) standard conditions Fig. 1 from Lin et al., 2017
blood lrrc32 expression decreased amount, abnormal mplsm10/sm10 (AB) standard conditions Fig. 1 from Lin et al., 2017
blood itga2b expression decreased amount, abnormal mplsm10/sm10 (AB) standard conditions Fig. 1 from Lin et al., 2017
head kidney itga2b expression decreased amount, abnormal mplsm10/sm10 (AB) standard conditions Fig. 1 from Lin et al., 2017
whole organism lrrc32 expression decreased amount, abnormal mplsm10/sm10 (AB) standard conditions Fig. 1 from Lin et al., 2017
whole organism itga2b expression decreased amount, abnormal mplsm10/sm10 (AB) standard conditions Fig. 1 from Lin et al., 2017
head kidney myb expression decreased amount, abnormal mplsm10/sm10 (AB) standard conditions Fig. 1 from Lin et al., 2017
head kidney lrrc32 expression decreased amount, abnormal mplsm10/sm10 (AB) standard conditions Fig. 1 from Lin et al., 2017
whole organism zfpm1 expression decreased amount, abnormal mplsm10/sm10 (AB) standard conditions Fig. 1 from Lin et al., 2017
whole organism gp9 expression decreased amount, abnormal mplsm10/sm10 (AB) standard conditions Fig. 1 from Lin et al., 2017
whole organism gp1bb expression decreased amount, abnormal mplsm10/sm10 (AB) standard conditions Fig. 1 from Lin et al., 2017
whole organism nfe2 expression decreased amount, abnormal mplsm10/sm10 (AB) standard conditions Fig. 1 from Lin et al., 2017
head kidney hematopoietic multipotent progenitor cell decreased amount, abnormal mplsm10/sm10; la2Tg standard conditions Fig. 1 from Lin et al., 2017
thrombocyte decreased amount, abnormal mplsm10/sm10; la2Tg perforation: blood vessel Fig. 4 from Lin et al., 2017
head kidney thrombocyte decreased amount, abnormal mplsm10/sm10; la2Tg standard conditions Fig. 1 from Lin et al., 2017
blood thrombocyte decreased amount, abnormal mplsm10/sm10; la2Tg standard conditions Fig. 1 from Lin et al., 2017
thromboblast cell population proliferation decreased occurrence, abnormal mplsm10/sm10; la2Tg standard conditions Fig. 2 from Lin et al., 2017
thrombocyte decreased amount, abnormal mplsm10/sm10; la2Tg standard conditions Fig. 1Fig. 3 from Lin et al., 2017
thrombocyte decreased amount, abnormal mplsm10/sm10; la2Tg chemical treatment by environment: TG101209 Fig. 3 from Lin et al., 2017
thrombocyte cell population proliferation decreased occurrence, abnormal mplsm10/sm10; la2Tg standard conditions Fig. 2 from Lin et al., 2017
thrombocyte decreased amount, abnormal mplsm10/sm10; sm9Tg control Fig. 6 from Lin et al., 2017
Citations